180 related articles for article (PubMed ID: 22471890)
21. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis.
Bartel F; Schulz J; Böhnke A; Blümke K; Kappler M; Bache M; Schmidt H; Würl P; Taubert H; Hauptmann S
Int J Cancer; 2005 Nov; 117(3):469-75. PubMed ID: 15906355
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin splice variants and polymorphisms in cancer progression and prognosis.
Briones-Orta MA; Avendaño-Vázquez SE; Aparicio-Bautista DI; Coombes JD; Weber GF; Syn WK
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):93-108.A. PubMed ID: 28254527
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis.
Walaszek K; Lower EE; Ziolkowski P; Weber GF
Br J Cancer; 2018 Nov; 119(10):1259-1266. PubMed ID: 30353046
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
26. Overexpressed ostepontin-c as a potential biomarker for esophageal squamous cell carcinoma.
Zhang MX; Xu YJ; Zhu MC; Yan F
Asian Pac J Cancer Prev; 2013; 14(12):7315-9. PubMed ID: 24460294
[TBL] [Abstract][Full Text] [Related]
27. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of Osteopontin splice variants in cancer.
An Y; Fnu G; Xie C; Weber GF
BMC Cancer; 2023 Apr; 23(1):373. PubMed ID: 37095438
[TBL] [Abstract][Full Text] [Related]
29. Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Ng CY; Chipitsyna G; Gong Q; Witkiewicz A; Weber GF; Denhardt DT; Yeo CJ; Arafat HA
Surgery; 2009 Aug; 146(2):232-40. PubMed ID: 19628079
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin expression in squamous cell cancer of the esophagus.
Wu IC; Wu MT; Chou SH; Yang SF; Goan YG; Lee JM; Chou YP; Bair MJ; Wang TE; Chen A; Chang WH; Kuo FC; Wu DC
World J Surg; 2008 Sep; 32(9):1989-95. PubMed ID: 18629582
[TBL] [Abstract][Full Text] [Related]
31. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up.
Cabiati M; Gaggini M; Cesare MM; Caselli C; De Simone P; Filipponi F; Basta G; Gastaldelli A; Del Ry S
Cytokine; 2017 Nov; 99():59-65. PubMed ID: 28711012
[TBL] [Abstract][Full Text] [Related]
33. Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential.
Chou CF; Huang CC; Bin Dabil N; Chang PL
Cancer Invest; 2021; 39(6-7):559-570. PubMed ID: 34043476
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Ferreira LB; Eloy C; Pestana A; Lyra J; Moura M; Prazeres H; Tavares C; Sobrinho-Simões M; Gimba E; Soares P
Eur J Endocrinol; 2016 Apr; 174(4):551-61. PubMed ID: 26811408
[TBL] [Abstract][Full Text] [Related]
35. Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease.
Grau JB; Poggio P; Sainger R; Vernick WJ; Seefried WF; Branchetti E; Field BC; Bavaria JE; Acker MA; Ferrari G
Ann Thorac Surg; 2012 Jan; 93(1):79-86. PubMed ID: 22093695
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical significance of osteopontin in calcified breast tissue.
Huan JL; Xing L; Qin XJ; Gao ZG; Pan XF; Zhao ZD
Asian Pac J Cancer Prev; 2012; 13(10):5219-23. PubMed ID: 23244138
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
40. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
